Los Angeles Capital Management LLC Avidity Biosciences, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 14,376 shares of RNA stock, worth $446,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,376Holding current value
$446,374% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$330 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$286 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$268 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$253 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$218 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.62B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...